ArticleFrontiers in surgery2026
Thulium fiber laser versus holmium:YAG laser for ureteroscopic lithotripsy: a single-center retrospective cohort study.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate and compare the clinical efficacy of thulium fiber laser (TFL) versus holmium:YAG laser (Ho:YAG) in the treatment of ureteral stones in a retrospective, non-randomized setting. Methods: We conducted a single-center retrospective cohort study of 132 patients with ureteral stones who underwent ureteroscopic laser lithotripsy between September 2023 to June 2025. Patients were stratified into TFL ( Results: Baseline characteristics were comparable between groups. The TFL group showed better intraoperative visual quality ( Conclusion: In this retrospective, non-randomized cohort study, our findings suggest that thulium fiber laser (TFL) may be associated with shorter operative and laser time, better intraoperative visualization, fewer intraoperative complications, and a higher stone-free rate (SFR) confirmed by non-contrast computed tomography (NCCT) at 12 weeks postoperatively. However, limited by the retrospective, non-randomized study design and short follow-up duration, well-designed prospective randomized controlled trials with extended safety surveillance periods are warranted to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.